West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
322.81
+1.01 (0.31%)
May 29, 2026, 4:00 PM EDT - Market closed
WST Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,221 | 3,074 | 2,893 | 2,950 | 2,887 | 2,832 | |
Revenue Growth (YoY) | 11.23% | 6.25% | -1.92% | 2.18% | 1.95% | 31.89% |
Cost of Revenue | 2,053 | 1,970 | 1,895 | 1,821 | 1,751 | 1,656 |
Gross Profit | 1,169 | 1,104 | 998.5 | 1,129 | 1,136 | 1,176 |
Selling, General & Admin | 405.1 | 393.6 | 338.5 | 353.4 | 316.9 | 362.8 |
Research & Development | 73.8 | 74.3 | 69.1 | 68.4 | 58.5 | 52.8 |
Other Operating Expenses | 34.6 | 51.2 | 21 | 31.4 | 26.8 | 7.9 |
Total Operating Expenses | 513.5 | 519.1 | 428.6 | 453.2 | 402.2 | 423.5 |
Operating Income | 655 | 584.9 | 569.9 | 676 | 734 | 752.3 |
Interest Income | 23.8 | 17.5 | 19.6 | 28 | 5.1 | 1 |
Interest Expense | -2.2 | -0.5 | -3 | -9 | -7.9 | -8.2 |
Other Non-Operating Income (Expense) | -1 | -1 | -1 | 3 | -51.3 | 3.8 |
Total Non-Operating Income (Expense) | 20.6 | 16 | 15.6 | 22 | -54.1 | -3.4 |
Pretax Income | 675.6 | 600.9 | 585.5 | 698 | 679.9 | 748.9 |
Provision for Income Taxes | 142.2 | 121.6 | 107.5 | 122.3 | 114.7 | 107.2 |
Net Income | 557.1 | 508.1 | 507.4 | 611.1 | 606.6 | 681.9 |
Minority Interest in Earnings | -14.4 | -14.4 | -14.7 | -17.7 | -20.7 | -20.1 |
Net Income to Common | 557.1 | 508.1 | 507.4 | 611.1 | 606.6 | 681.9 |
Net Income Growth | 15.82% | 0.14% | -16.97% | 0.74% | -11.04% | 87.54% |
Shares Outstanding (Basic) | 72 | 72 | 73 | 74 | 74 | 74 |
Shares Outstanding (Diluted) | 73 | 73 | 74 | 75 | 76 | 76 |
Shares Change (YoY) | -1.09% | -1.36% | -2.13% | -0.66% | -0.66% | 0.66% |
EPS (Basic) | 7.52 | 6.83 | 6.75 | 7.98 | 7.87 | 8.89 |
EPS (Diluted) | 7.48 | 6.79 | 6.69 | 7.88 | 7.73 | 8.67 |
EPS Growth | 17.42% | 1.49% | -15.10% | 1.94% | -10.84% | 89.72% |
Shares Outstanding | 70.9 | 72 | 72.3 | 73.5 | 74.1 | 74.2 |
Free Cash Flow | 458 | 468.9 | 276.4 | 414.5 | 439.4 | 330.6 |
Free Cash Flow Growth | -2.33% | 69.64% | -33.32% | -5.67% | 32.91% | 10.90% |
Free Cash Flow Per Share | 6.31 | 6.45 | 3.75 | 5.50 | 5.80 | 4.33 |
Dividends Per Share | 0.860 | 0.850 | 0.810 | 0.770 | 0.730 | 0.690 |
Dividend Growth | 1.18% | 4.94% | 5.20% | 5.48% | 5.80% | 6.15% |
Gross Margin | 36.28% | 35.91% | 34.51% | 38.28% | 39.36% | 41.52% |
Operating Margin | 20.34% | 19.03% | 19.70% | 22.92% | 25.43% | 26.57% |
Profit Margin | 16.85% | 16.06% | 17.03% | 20.12% | 20.30% | 23.37% |
FCF Margin | 14.22% | 15.25% | 9.55% | 14.05% | 15.22% | 11.68% |
EBITDA | 831.6 | 756.3 | 725.3 | 813.3 | 854.6 | 874.6 |
EBITDA Margin | 25.82% | 24.60% | 25.07% | 27.57% | 29.60% | 30.89% |
EBIT | 655 | 584.9 | 569.9 | 676 | 734 | 752.3 |
EBIT Margin | 20.34% | 19.03% | 19.70% | 22.92% | 25.43% | 26.57% |
Effective Tax Rate | 21.05% | 20.24% | 18.36% | 17.52% | 16.87% | 14.31% |